TATAA Biocenter

Goteborg, Sweden Founded: 2001 • Age: 25 yrs
Molecular analysis services for research and drug development are offered.

About TATAA Biocenter

TATAA Biocenter is a company based in Goteborg (Sweden) founded in 2001.. TATAA Biocenter has completed 1 acquisition, including Life Genomics. TATAA Biocenter offers products and services including qPCR/dPCR Assays, RNA Sequencing, DNA Sequencing, and Biomarker Analysis. TATAA Biocenter operates in a competitive market with competitors including Tessera Therapeutics, Phase Genomics, Hexagon Bio, NovellusDx and BGI, among others.

  • Headquarter Goteborg, Sweden
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Bio Center S.R.O.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $27.43 K (USD), Grant

    Dec 01, 2023

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of TATAA Biocenter

TATAA Biocenter offers a comprehensive portfolio of products and services, including qPCR/dPCR Assays, RNA Sequencing, DNA Sequencing, and Biomarker Analysis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Quantify biomarkers and genetic targets for drug development applications

Provides sequencing from extraction to analysis for research needs

Sequences genomes and panels to identify genetic variations

Analyzes molecular biomarkers in biological samples

Funding Insights of TATAA Biocenter

  • Total Funding
  • Total Rounds 8
  • Last Round Grant — $27,426
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2023 Amount Grant - TATAA Biocenter Valuation

investors

Jan, 2021 Amount Grant - TATAA Biocenter Valuation

investors

Apr, 2020 Amount Grant - TATAA Biocenter Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in TATAA Biocenter

TATAA Biocenter has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by TATAA Biocenter

TATAA Biocenter has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Life Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Genetic tests for fetal health and personal wellness are developed.
2014
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - TATAA Biocenter

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Tataa Biocenter Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of TATAA Biocenter

TATAA Biocenter operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tessera Therapeutics, Phase Genomics, Hexagon Bio, NovellusDx and BGI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
New genome engineering technology is provided for treating multiple diseases.
domain founded_year HQ Location
Laboratory and computational services for DNA proximity analysis are provided.
domain founded_year HQ Location
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
domain founded_year HQ Location
Developer of technology for precision cancer diagnosis and therapies
domain founded_year HQ Location
BGI is engaged in genomics and precision medicine solutions.
domain founded_year HQ Location
Genomic services are provided for the life sciences industry.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Tataa Biocenter

Frequently Asked Questions about TATAA Biocenter

When was TATAA Biocenter founded?

TATAA Biocenter was founded in 2001 and raised its 1st funding round 12 years after it was founded.

Where is TATAA Biocenter located?

TATAA Biocenter is headquartered in Goteborg, Sweden. It is registered at Goteborg, Vastra Gotaland, Sweden.

What does TATAA Biocenter do?

TATAA Biocenter was founded in 2001 in Gothenburg, Sweden, and operates as a contract research organization in the pharmaceutical sector. Bioanalytical services are provided to support scientific research, clinical trials, and drug development. A range of molecular analysis techniques is utilized, including PCR services, next-generation sequencing, and proteomics. Operations focus on assisting pharmaceutical companies with analytical needs in a regulated environment.

Who are the top competitors of TATAA Biocenter?

TATAA Biocenter's top competitors include Tessera Therapeutics, Phase Genomics and BGI.

What products or services does TATAA Biocenter offer?

TATAA Biocenter offers qPCR/dPCR Assays, RNA Sequencing, DNA Sequencing, and Biomarker Analysis.

How many acquisitions has TATAA Biocenter made?

TATAA Biocenter has made 1 acquisition, including Life Genomics.

Who are TATAA Biocenter's investors?

TATAA Biocenter has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available